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RNaseECP/RNase 3) and the skin derived ribonuclease 7 (RNase 7) are members of the
RNase A superfamily. RNase 3 is mainly expressed in eosinophils whereas RNase 7 is primarily secreted by
keratinocytes. Both proteins present a broad-spectrum antimicrobial activity and their bactericidal
mechanism is dependent on their membrane destabilizing capacities. Using phospholipid vesicles as
membrane models, we have characterized the protein membrane association process. Confocal microscopy
experiments using giant unilamellar vesicles illustrate the morphological changes of the liposome
population. By labelling both lipid bilayers and proteins we have monitored the kinetic of the process. The
differential protein ability to release the liposome aqueous content was evaluated together with the
micellation and aggregation processes. A distinct morphology of the protein/lipid aggregates was visualized
by transmission electron microscopy and the proteins overall secondary structure in a lipid microenviron-
ment was assessed by FTIR. Interestingly, for both RNases the membrane interaction events take place in a
different behaviour and timing: RNase 3 triggers ﬁrst the vesicle aggregation, while RNase 7 induces leakage
well before the aggregation step. Their distinct mechanism of action at the membrane level may reﬂect
different in vivo antipathogen functions.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Ribonucleases (RNases) are found in all living organisms and play
an important role in the metabolism of cellular RNA. However, other
biological functions rather than the intrinsic ribonucleolytic activity
have been described for several members of the RNase A superfamily
[1–3]. Several RNases have antipathogen activities [4–6] and an
ancestral host defense function was suggested [7].
The eosinophil cationic protein (ECP or RNase 3) is a human host
defense ribonuclease involved in inﬂammatory processes mediated by
eosinophils. ECP is a potent cytotoxic molecule, has bactericidal and
helminthotoxic properties and is active against the respiratory
syncytial virus (RSV). The ECP levels in different biological ﬂuids
correlate with the eosinophil activity and are used as an inﬂammatory
marker [8,9].
Lehrer et al. ﬁrst reported ECP bactericidal action and the protein
ability to permeabilize the outer and inner E. colimembranes [10]. ECP
bactericidal activity is indeed effective against both Gram-negativeosphocholine; DOPG, 1,2-dio-
8-Aminonaphthalene-1,3,6-tri-
idiniumbromide; LUV, large
34 93 5811264.
ll rights reserved.and Gram-positive strains [10–12] and its antimicrobial activity is
dependent on its action at the cytoplasmic membrane and bacteria
wall levels [13,14]. Early studies by Young and collaborators [15]
already reported ECP ability to destabilize synthetic lipid bilayers. ECP
bactericidal activity correlates with its membrane disruption ability
and is dependent upon both surface exposed hydrophobic and
cationic residues [12,16]. ECP can bind and partially insert into the
lipid bilayers, promoting the lipid vesicles aggregation and lysis,
following a “carpet like” mechanism [13].
Ribonuclease 7 is an antimicrobial protein expressed in skin, liver,
kidney, skeletal muscle and heart [17,18]. It shows a low RNase activity
in degradation of yeast tRNAs and has no antiviral activity for the
respiratory sincitial virus. Human RNase 7 was originally identiﬁed
from a screening protocol searching for antimicrobial proteins in skin.
RNase 7 revealed a broad spectrum antimicrobial activity against
Gram-negative and Gram-positive strains [17,19], and a remarkably
potent activity against Enterococcus faecium [17]. RNase 7 has also a
high antimicrobial activity against Pseudomonas aeruginosa and the
yeast Pichia pastoris [20]. RNase 7 mRNA expression was detected in
various epithelial tissues including skin, gut, respiratory and genitour-
inary tract [19]. RNase 7 expression responds to inﬂammatory agents
and bacterial infection [17]. Molecular cloning from skin-derived
primary keratinocytes and puriﬁcation of RNase 7 from supernatants
of cultured primary cells indicate that keratinocytes represent the
major cellular source in skin. In addition to a constitutive expression,
Fig. 1. Comparison of the blast alignment of RNase 3 and RNase 7 primary sequences. Secondary structure of RNase 3 is depicted. Strictly conserved residues are boxed in dark grey,
and conserved residues, as calculated by a similarity score are boxed in white. Cysteine pairings for disulﬁde bridges are numbered below. The ﬁgure was created using the ESPrit
software [48].
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interleukin-1, interferon-, and bacterial challenge [17]. RNase 7 site-
directed mutagenesis studies have identiﬁed some lysine clusters
required for the protein antimicrobial action [20].
Both RNase 3 and RNase 7, as representative members of the RNase
A family, display RNase activity for most common RNA substrates,
although its RNase activity has been reported not necessary for the
antibacterial action [11,20].
In this study we present a comparison of the interaction mechan-
isms of RNase 3 and RNase 7 with lipid bilayers using a synthetic
membrane model. Although both proteins belong to the RNase
superfamily and show a high cationicity, they have accumulated an
unusual number of either Arg (RNase 3) or Lys (RNase 7) residues
(Fig. 1) by a divergent evolution path. We present here evidences that
both proteins exhibit a distinct membrane interaction behaviour.
2. Materials and methods
2.1. Materials
1,2-Dioleoyl-sn-glycero-3-phosphocholine(DOPC) and 1,2-dio-
leoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (DOPG) were from
Avanti Polar Lipids, Birmingham, AL.
8-Aminonaphthalene-1,3,6-trisulfonic acid disodium salt (ANTS),
p-xylene-bispyridiniumbromide (DPX), Alexa Fluor 488 Protein
Labelling kit, Vibrant DiI cell-labelling solution and Concanavalin-
Alexa Fluor 488 were fromMolecular Probes, Invitrogen, Carlsbad, CA.
pET11 expression vector and E. coli BL21(DE3) cells were from
Novagen, Madison,WI. pFLAG CTS/RNase 7 was kindly provided by
Helene Rosenberg (NIAID, NIH, Bethesda, Maryland).
2.2. Preparation of recombinant proteins
Construction of the RNase 7 expression plasmid was performed
using the plasmid construct pFLAG CTS/RNase 7. Plasmid pFLAG CTS/
RNase 7 [19] was subjected to polymerase chain reaction for
subcloning of RNase 7 gene into the pET11c plasmid vector. The ﬁnal
sequence corresponds to RNase 7 lacking the leader sequence and
having an additional N-terminal methionine residue (pET11c/RNase
7). RNase 3 was expressed using the previously constructed expres-
sion plasmid (pET11c/ECP) [21]. Protein expression in the E. coli BL21
(DE3) strain (Novagen, Madison, WI), folding of the proteins from
inclusion bodies, and the puriﬁcation steps were carried out as
previously described [21].
2.3. LUV liposome preparation
Large unilamellar vesicles (LUVs) of a deﬁned size (about 200 nm)
were prepared as previously described (Torrent et al., 2007). LUVs
were obtained from a vacuum-drying lipid chloroform solution byextrusion through 800, 400, and 200 nm polycarbonate membranes.
The lipid suspension was frozen and thawed ten times prior to
extrusion. Liposomes were obtained containing either DOPC/DOPG
(3:2 molar ratio), or pure DOPC. A 1 mM stock solution of liposome
suspension in 10 mM Tris–HCl and 0.1 M NaCl at pH 7.4 was prepared.
2.4. LUV liposome aggregation
Aggregation of LUV lipid vesicles was monitored by measuring the
absorbance at 470 nm (A470) using a Cary 400 spectrophotometer and
cuvettes with an optical path of 1 cm. Prior to the addition of proteins,
the vesicles were allowed to equilibrate for 15 min. Final assay
conditions were: 200 μM lipid concentration and from 0.04 to 2 μM
protein range concentration, in 10 mM HEPES, pH 7.4 buffer.
2.5. Dynamic light scattering
Changes in liposome population were analysed using a Microtrac
Ultraﬁne Particle Analyser 150 spectrometer (UPA). This device
measures vesicle size distribution by dynamic light scattering operat-
ing with heterodyne detection [22]. The UPA is equipped with a diode
laser with a wavelength of 780 nm and a nominal output of 3 mW of
optical power. RNases and DOPC/DOPG LUV were incubated at room
temperature and the mean size of liposome population was recorded.
The incubation buffer was 10 mM Tris–HCl, and 0.1 M NaCl, pH 7.4.
Measurements were performed at 1.5 mM ﬁnal liposome concentra-
tion and the protein concentration used was 1.5 μM and 3.75 μM to
achieve a protein–lipid ratio of 1/1000 and 1/400 respectively. The
results are presented as the volume (or weight) distribution.
2.6. GUV liposome preparation
Giant unilamellar vesicles (GUVs) were used for confocal micro-
scopic observation of the membrane disruptive effects of the proteins.
To obtain GUVs, we used themethod of Needham et al. [23] with some
modiﬁcation. Brieﬂy, DOPC:DOPG lipids (3:2) or pure DOPC were
dissolved together in chloroform to a ﬁnal concentration of 10mg/mL.
Subsequently, 200 μL aliquots were placed in the bottom of a 1.5-cm
diameter, 10-mL glass tube. When required, phospholipids were
labelled by adding 1 μl of Vibrant DiI solution and the sample was
gently mixed with a vortex. The solvent was dried at room
temperature in a stream of nitrogen gas, to provide a thin lipid ﬁlm.
After removal of residual solvent under high vacuum for at least 1 h,
the ﬁlm was prehydrated with a stream of water-saturated air for
30 min at 43–45 °C and then fully rehydrated by addition of 5 mL of a
0.1 M saccharose solution. The liposomes, which appear as an almost
transparent, milky-pinked cloud in the middle of the solution, were
collected and stored at 4 °C in polypropylene tubes. GUV liposome
concentration was checked to be 1 mM ﬁnal concentration. Vesicles
obtained by this procedure had diameters ranging from 2 to 15 μm.
Fig. 2. Proﬁle comparison of the aggregation and leakage processes as a function of the
lipid/proteinmolar ratio, registered after 1 hour of incubation of the LUVwith (A) RNase
3 and (B) RNase 7. Liposome aggregation was followed by recording the increase of
absorbance at 470 nm and leakage activity was assayed by registering the release of the
ANTS/DPX liposome content. Filled squares (leakage) andempty triangles (aggregation).
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The ANTS/DPX liposome leakage ﬂuorescence assay was per-
formed as described previously [13]. Brieﬂy, a single population of LUV
of DOPC:DOPG 3:2 composition containing 12.5 mM ANTS, 45 mM
DPX, 20 mM NaCl, and 10 mM Tris–HCl at pH 7.5 was obtained.
Unencapsulated material was separated from the vesicles by gel
ﬁltration on Sephadex G-25 (Amersham Pharmacia Biotech) using
20 mM Tris–HCl at pH 7.5 containing 0.1 M NaCl as an elution buffer.
The lipid concentration was determined by a colorimetric assay
method for free and phosphorylated glyceric acids [24]. The ANTS/
DPX liposome suspension was diluted to a 30 μM ﬁnal lipid
concentration andwas incubated at room temperature in the presence
of the protein. The leakage activity was assayed at different protein
concentrations (from 0.04 to 3 μM) by following the release of the
liposome content. Fluorescence was measured using a 386 nm
excitation wavelength and 535 nm emission wavelength. Slits were
set at 5 and 10 nm for excitation and emission, respectively. Cut-off
ﬁlters for excitation and emission wavelengths were set at 250–395
and 430–1100 nm, respectively. The percentage of leakage (% L)
produced by the proteins after 1 h of incubation with the liposomes
was calculated with the following equation:kL=100− Fp−F0F100−F0, where
Fp is the ﬁnal ﬂuorescence intensity after the addition of the protein
(1 h), F0 and F100 are the ﬂuorescence intensities before the addition
of the protein and after the addition of 0.5% Triton X-100. For each
protein concentration, three calculated leakage values were averaged.
2.8. Fluorescent labelling of RNases
RNase 3, RNase 7 and RNase A were labelled with the Alexa Fluor
488 ﬂuorophor, following the manufacturer's instructions, as pre-
viously described [14]. To 0.5 mL of a 2 mg/mL protein solution in
phosphate saline buffer (PBS), 50 μL of 1 M sodium bicarbonate, pH
8.3, were added. The protein is incubated for 1 h at room temperature,
with the reactive dye, with stirring, following the manufacturer's
conditions. The labelled protein was separated from the free dye by a
PD10-desalting column.
2.9. Confocal microscopy
Experiments were carried out in a glass-coverslide system. 10 μl of
1 mM GUV liposomes were mixed with different concentrations of
RNase 3 or RNase 7 (1–10 μM) and images were immediately
recorded. RNase Awas used in all cases as a negative control. Confocal
images of the liposomeswere captured using a laser scanning confocal
microscope (Leica TCS SP2 AOBS equipped with a HCX PL APO 63×1.4
oil immersion objective, Germany). RNase 3 and RNase 7 labelled with
Alexa Fluor 488 were excited using a 488-nm argon laser (515–
540 nm emission collected) and Vibrant DiI was excited using an
orange diode (588–715 nm emission collected). Similar experiments
were carried out using Alexa Fluor 488-RNase A as a control. For time-
lapse experiment, Life Data Mode software (Leica) was used,
obtaining an image every 30 s in 30 min of total time experiment.
To probe high molecular weight compound leakage, liposomes
containing concanavalin A-Alexa Fluor 488 (∼104 kDa) were used.
Concanavalin GUV liposomeswere prepared as described above, using a
0.1 M saccharose, 10 mM concanavalin A-Alexa Fluor 488 rehydratation
solution. Unencapsulated material was separated from the vesicles by
gel ﬁltration on Sephadex G-25 (Amersham Pharmacia Biotech) using
0.1 M saccharose solution as elution buffer. Proﬁle analysis of
ﬂuorescence intensity wasmeasured using the Leica Confocal Software.
2.10. Transmission electron microscopy
Transmission electron microscopy was applied to visualize the
morphology of protein/lipid aggregates, following the describedmethodology [25] with minor modiﬁcations. Brieﬂy, LUV liposomes
were diluted at a ﬁnal concentration of 200 μM, and incubated with
0.5 mM of RNase 3 or 1 mM of RNase 7 in 10 mMHEPES buffer, pH 7.4.
The mixtures were incubated at room temperature for 40 min, after
which 20 μL of samples were applied to carbon-coated grids and
negatively stainedwithuranil acetate. Sampleswere examined in a JEOL
JEM 2011 (Jeol Ltd., Tokio, Japan) transmission electron microscope.
2.11. Fourier transformed infrared spectroscopy (FTIR)
For the FTIR measurements, lyophilized RNase 3 or RNase 7 were
dissolved in deuterated 10 mM buffer HEPES, pD 7.4. Protein samples
were stored overnight in the corresponding deuterated buffer in order
to ensure a complete H/D exchange. The samples were sandwiched
between two CaF2 windows separated by a 50-mm Teﬂon spacer at a
ﬁnal concentration of 10 mg/mL. LUV of DOPC:DOPG phospholipids
were prepared to a ﬁnal concentration of 10 mM. Protein–LUV
samples were incubated for 15 min. The temperature was controlled
with a Julabo circulating bath. For each spectrum, 1000 scans at a
nominal resolution of 2 cm−1 were averaged with a sample shuttle
device using a FTIR-Mattson Polaris spectrometer. The spectrometer
was equipped with a cooled nitrogen mercury-cadmium-telluride
(MCT) detector, and it was continuously purged with dry air (dew
point lower than−60 °C). To obtain the pure spectrum of the protein,
spectra of the solvent were recorded under identical conditions. The
criterion for a good subtraction was to obtain a ﬂat line between
1800 cm−1 and 2000 cm−1. All spectra were also corrected for
atmospheric water. The spectra were deconvoluted using an FHHH of
15 cm−1 and a k factor of 1.8. In order to measure the relative areas of
the amide I9 band components, deconvoluted spectra were curve-
ﬁtted by means of a least-squares iterative program.
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3.1. LUV liposome aggregation
The increase of absorbance at 470 nmwavelength and DLS analysis
were used to evaluate the lipid vesicle aggregation process after
protein addition. DLS registered no increase in the mean size diameter
of liposomes population for DOPC vesicles, even at a 1/100 protein/
lipid molar ratio [13]. The lack of aggregation activity when using
DOPC LUV was now also conﬁrmed for both RNases. The spectro-
photometric method was proven useful to monitor the liposome
aggregation process (Fig. 2), corroborating the data recorded by
dynamic light scattering [13].
RNase 3 begins to induce lipid vesicle aggregation at a protein/
lipid molar ratio of 1/2000 and achieves a 50 % effect at a 1/900
protein/lipid molar relation. (Fig. 2A). The data reveal a high RNase 3
ability to aggregate lipid vesicles from a nanomolar protein
concentration range, which corresponds to a protein /lipid molar
ratio of about 1/2000.
In the other hand, RNase 7, presents a lower aggregation ability as
we cannot observe lipid vesicle aggregation until a protein/lipidmolar
ratio of 1/500 is reached and the 50 % effect is achieved at an
approximately 1/300 relation (Fig. 2B).Fig. 3. Comparative kinetic analysis of the liposome aggregation and leakage processes trigge
RNase 3 and RNase 7 at 1/1000 (empty triangles) and 1/400 (empty circles) protein–lipid mo
and RNase 7 at 1/1000 and 1/400 protein–lipid molar ratio. Estimation of the average diam
liposome diameter at different times: 0 min (empty circles), 20 min (empty triangles) and
sample precipitation and cannot be evaluated. Average diameter values over 2 μmcannot be aDLS allowed a direct estimation of the evolution of the liposome
population mean size at two representative protein/molar lipid ratios
(Fig. 3). The size distribution at distinct time intervals up to 1 hour for
a 1/400 and a 1/1000 protein/lipid molar ratio for both RNases
illustrates the process progress for each condition. Comparison of the
distribution proﬁles indicates a pronounced shift towards higher
diameter size values for RNase 3 in relation to RNase 7.
The sigmoidal shape of liposome aggregation as a function of the
lipid/protein ratio for both, RNase 3 and RNase 7 (Fig. 2), suggests a
cooperative mechanism. In this line, both RNases have to accumulate
several molecules at the lipid surface to trigger the aggregation
process. These results show that despite the overall high cationicity of
both proteins, and their structural primary and tertiary homology (Fig.
1), the aggregation behaviour is distinct, indicating that aggregation of
lipid vesicles in RNase 3 is an earlier event than in RNase 7 in the
protein–membrane interaction process.
3.2. ANTS/DPX liposome leakage assay
We have evaluated the proteins ability to trigger the leakage of the
liposome aqueous content by the ANTS/DPX ﬂuorescence assay. ANTS
is a low molecular weight marker (427 Da) that allows the detection
of local membrane disruption.red by RNases 3 and 7. (A) Leakage kinetics of 3:2 DOPC:DOPG liposomes incubated with
lar ratio. (B) Aggregation kinetics of 3:2 DOPC:DOPG liposomes incubated with RNase 3
eter size was assessed by DLS. Results are displayed as the volume percentage for each
60 min (empty squares). Incubation with RNase 3 for 60 min at 1/400 ratio lead to full
ccurately predicted and values aremerely included in the graph for internal comparison.
Fig. 4. Study of the liposome population morphology visualized by confocal microscopy. (A) DOPC/DOPG liposomes incubated with RNase 3 at 0, 10 and 30min (top) andwith RNase
7 at 0, 5 and 10 min (bottom). (B) DOPC liposomes after protein addition for 30 min. Proteins were labelled with AlexaFluor 488 (green signal) and liposomes with Vibrant DiI (red
signal). Panels include the overlay of both signals. RNase 3 concentration was 4 μM (protein/lipid ratio 1/400) and RNase 7 concentration was 8 μM (protein/lipid ratio 1/200).
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[12,13] and RNase 7 at even 1/30 protein/lipid ratio (data not shown).
Using DOPC/DOPG LUV, leakage activity is registered as an increase in
ﬂuorescence intensity. No content release is detectedwhenusingRNase
A as a control [12]. Both RNase 3 and RNase 7 showa signiﬁcant leakage
activity, although a distinct pattern is observed in each case (Fig. 2).Fig. 5. Study by confocal microscopy of RNase 3 and RNase 7 location in the protein–lipid
labelled with Vibrant DiI. Left panels correspond to the Vibrant DiI ﬂuorescent marker (red
correspond to the labelled proteins with Alexa Fluor 488 (green signal), excited using a 488-
overlay of both signals. (A) RNase 3 incubation for 30 min with 3:2 DOPC/DOPG liposomes;
ﬂuorescence intensity for labelled RNases (in green) and phospholipids (in red). The graph r
to a protein/lipid molar ratio of 1/800.RNase 3 requires a higher protein concentration to present a
signiﬁcant leakage activity, which is registered at a protein/lipid ratio
of 1/300 (Fig. 2A). This leakage ability is shown with a considerable
delay after the onset of the liposome vesicle aggregation. These results
suggest that RNase 3 leakage activity is induced by membrane
destabilization when vesicle aggregation has already taken place. Thevesicles samples. Proteins were labelled with AlexaFluor 488 and phospholipids were
signal) excited using an orange diode (588–715 nm emission collected). Central panels
nm argon laser (515–540 nm emission collected). Right-hand panels correspond to the
(B) RNase 7 incubation for 30 min with 3:2 DOPC/DOPG liposomes and (C) proﬁles of
epresents a section of a single liposome. Protein concentrationwas 2 μM, corresponding
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parallel to the precipitation event (Fig. 2A), suggesting that the
content release is a consequence of the aggregation process.
RNase 7, on its turn, presents a distinct behaviour. We observe that
RNase 7 begins to present a leakage activity at a protein/lipid ratio
above 1/900, corresponding to amuch lower protein concentration. In
fact RNase 7 can release the low molecular weight ANTS ﬂuorofor
before any aggregation event occurs (Fig. 2B).
A direct recording of the release of the liposome content indicates
that the process is fast and the ﬂuorescence signal reaches already a
maximumplateau after 10–15min (Fig. 3A). A side by side comparison
of the kinetic of the aggregation and leakage processes during 1 hour
conﬁrms that RNase 3 triggers already the vesicles aggregation when
no leakage is registered (protein/lipid ratio 1/1000). On the other
hand, leakage is already detectable for RNase 7 at a 1/1000 ratio while
no change on the liposomemean size is observed. Moreover, for RNase
7 at a 1/400 ratio, when a 20% of the liposome content is released,
most of the vesicles still retain their original size.
3.3. Confocal microscopy
Confocal microscopy experiments using giant unilamellar vesicles
(GUVs) allow the visualization of the conformational changes on theFig. 6. Study on the liposome aggregationprocess byRNase 3 (A) and RNase 7 (B). Liposome ag
microscopy upon incubation for 40 min. Proteins labelled with Alexa Fluor 488 (green signal)
DiI (red signal) was excited using an orange diode (588–715 nm emission collected). Three
steps of the lipid vesicles aggregation process, taking as a reference the registered proﬁle of t
b) 2 μM (lipid/protein ratio 800) and c) 4 μM (lipid/protein ratio 400). B) RNase 7: a) absenvesicle population triggered by protein incubation (Fig. 4). We have
ﬁrst conﬁrmed that no activity is observed for pure neutral vesicles.
The lack of activity on DOPC liposomes indicates again that the
interaction process is electrostatically driven, as no leakage, fusion or
aggregation is observed. The conformational changes of the DOPC/
DOPG vesicle population have been monitored at different timing and
protein concentrations. RNase 3 at 4 μM triggers rapidly the
aggregation process, visible from 10 min onwards, and the lipid
vesicles precipitation takes place after 30 min. In the initial
aggregation stage, formation of protein–lipid patches in the mem-
brane can be observed and an intensive vesiculation of liposomes is
also remarkable (Fig. 4A).
The kinetic of the aggregation process for RNase 7 seems to be
faster than RNase 3, but a minimum concentration of 10 μM has to be
reached to observe it (Fig. 4A). Once this protein threshold is reached,
the precipitation even takes place in only about 10 min. Moreover,
although protein–lipid patches can also be observed, no prior
aggregation has been detected in this case.
By labelling the proteins and liposomes with the speciﬁc
ﬂuorescent markers we could directly assess the membrane integrity
and the protein behaviour, during the process of vesicle aggregation.
We have conﬁrmed that both RNases do not internalize into the
liposome vesicles (Fig. 5). RNase 3 remains at the membrane level,gregationprocesswas followed by the visualization of liposomemorphology byconfocal
were excited using a 488-nm argon laser (515–540 nm emission collected) and Vibrant
representative protein/lipid molar ratio were chosen for the comparison of the distinct
he increase of the absorbance at 470 nm. A) RNase 3: a) 1 μM (lipid/protein ratio 1600);
ce of protein; b) 5 μM (lipid/protein ratio 200) and c) 10 μM (lipid/protein ratio 100).
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precipitation. In this line, labelled RNase 7 also remains at the
membrane level and is not internalized into the vesicles. The
ﬂuorescence intensity proﬁles of a section of a single liposome also
conﬁrmed that no labelled proteins are internalized into the
liposomes (Fig. 5C). We observe the Vibrant DiI red signal following
the vesicle lipid bilayer and all the AlexaFluor green signal located at
the external sides of the vesicle.
The liposome aggregation process analysed in detail by confocal
microscopy, allows to distinguish three main steps (Fig. 6). For RNase
3 (Fig. 6A) we can identify a initial range (around a protein/lipid ratio
of 1/2000) where the aggregation process is triggered but cannot be
visualized by confocal microscopy (a). Aggregation is then patent at a
value of 1/800 (b) and this aggregation may turn into vesicle–protein
precipitation if the protein/lipid relation is increased at a value of 1/
400 (c).
On its turn, RNase 7 (Fig. 6B) is able to induce aggregation of lipid
vesicles from a protein/lipid ratio of 1/400 but this aggregation is not
visible by confocal microscopy at a 1/200 ratio (b). This aggregation
may turn into vesicle–protein precipitation if the protein/lipid
relation is increased at a value of 1/100 (c). Confocal microscopy
images suggest that both RNase produces vesicle aggregates with
distinct morphological conformation, as further inspection by trans-
mission electron microscopy corroborates.
Additionally, experiments with GUVs with incorporated concana-
valin-Alexa Fluor 488 have also proven useful to directly assess any
potential membrane disruption event. The results obtained using
liposomes containing concanavalin A-Alexa Fluor 488 have shown
that for RNase 7 there is no signiﬁcant content release of high
molecular weight compounds at protein/ lipid molar ratio where
leakage of ANTS/DPX is already taking place (Fig. 7). The ﬂuorescence
intensity proﬁles of both concanavalin (green signal) and vesicle lipid
bilayer (red signal) conﬁrms that concanavalin is totally retained
inside the vesicles (Fig. 7B).Fig. 7. (A) Confocal microscopy of concanavalin A containing liposomes incubated with RN
excited using an orange diode (588–715 nm emission collected). Central panels correspond t
argon laser (515–540 nm emission collected). Right-hand panels correspond to the ove
corresponding to a 50% of leakage activity. (B) Proﬁles of ﬂuorescence intensity. AlexaFluo
signal in red. The graph represents a section of a single liposome.The results suggest for RNase 7 a local membrane destabilization,
forming protein–lipid structures that may release low molecular
weight compounds whereas high molecular weight compounds
remain encapsulated inside the liposome structure. However, confocal
microscopy using liposomes containing concanavalin A-Alexa Fluor
488 could only be assessed by selecting isolated ﬂoating liposomes.
Therefore, protein/lipid conditions where aggregation is predominant
could not be analysed, and the methodology does not allow to check if
the sedimented liposome aggregates retain or not the vesicles content.
In the case of RNase 3, the triggering of the leakage process
requires higher protein concentrations, when aggregates are already
formed, and therefore the concanavalin experiment was not feasible.
Besides, the analysis would not provide any additional information, as
RNase 3 would trigger the vesicles lysis, releasing simultaneously the
low and high molecular weight markers.
3.4. Transmission electron microscopy
TEM micrographs of negatively stained samples allowed the
visualization of the protein–lipid precipitate. This technique was
suitable to analyse the morphology of the vesicles aggregates (Fig. 8).
A distinct conformation for the liposome aggregates is observed for
both proteins, corroborating the pattern tendency suggested by
confocal microscopy analysis. For both proteins we have analysed a
precipitate sample obtained after incubation with the protein for
40 min at a protein/lipid ratio of 1/400 for RNase 3 and 1/200 for
RNase 7, which corresponds to a condition where the aggregation
process is completed. Big aggregates are observed in both cases.
However, TEM images suggest that the aggregate conformation is
distinct. While the ﬁnal LUV aggregate triggered by incubation with
RNase 7 is more dense and elongated; spherical structures retaining
the liposomes original conformation are still patent in the RNase 3 /
liposomes precipitate. This difference may depend on the distinct ﬁrst
step registered for both proteins, as drawn in the scheme depicted toase 7 for 30 min. Left panels correspond to the Vibrant ﬂuorescent marker (red signal)
o the labelled concanavalin with Alexa Fluor 488 (green signal), excited using a 488-nm
rlay of both signals. Images were taken at the protein/lipid molar ratio of 1/500,
r 488-concanavalin signal represented in green and Vibrant DiI labelled phospholipids
Fig. 8. TEM and negative staining micrographs of LUV incubated for 30min at a 1/400 and 1/200 protein/lipid ratio for RNase 3 and RNase 7 respectively. Conditions were selected to
visualize the ﬁnal precipitate morphology: A) control, B) RNase 3 and C) RNase 7.
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lysis of liposomes at a low protein concentration, before any vesicle
aggregation is activated, RNase 3 is agglutinating “intact” vesicles. This
would explain the formation for RNase 7 of more lipid supra
structures, where the original LUV shape is completely lost.
3.5. Fourier transformed infrared spectroscopy (FTIR)
FTIR was used to monitor secondary structure changes during
interaction of both, RNase 3 and RNase 7, with LUV liposome
membranes. The deconvoluted spectra were obtained and peaks
were identiﬁed according to the literature established assignments
[26–28]. Previous FTIR spectra of RNase 3 at pD 5.5 and 7.5 were
already characterized [29]. Using this technique, we have compared
the overall protein structures in the absence and presence of lipidFig. 9. Schematic drawing to illustrate the proposed timing of the events involved in the prote
proposed model includes the following steps: the protein molecules association to vesiclesvesicles. No secondary structure modiﬁcation of neither RNase 3 nor
RNase 7 was detected. These results suggest that membrane lysis
mechanism of action does not involve structure changes or modiﬁca-
tion of the protein overall conformation.
4. Discussion
RNase 3 and RNase 7 are human RNases potentially involved in
host defense [3,4,20,30–34] that show a cytotoxic activity against a
wide range of pathogens [5]. Their antimicrobial mechanism of action
is mostly dependent on their membrane destabilization ability
[4,8,20].
We have previously characterized RNase 3 bactericidal action
[12,14] and its action on synthetic membrane models [12,13]. Analysis
by electron microscopy and DLS revealed how the protein triggeredin–lipid association process for RNases 3 and 7, as detailed in the discussion section. The
lipid bilayers, the vesicles aggregation process and the inner content release.
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before any signiﬁcant content leakage. A micellation process was also
suggested and the results for RNase 3 were interpreted as indicative of
a membrane destabilization “carpet-like” mechanism [13].
We have now further evaluated RNase 3 activity on synthetic
membranes using LUV and GUV, and compared its action with RNase
7. Analysis of both RNases action by biophysical and microscopy
methodologies, using as a model large and giant unilamellar lipid
vesicles, allowed a careful characterization of the process.
We ﬁrst conﬁrmed that RNase 7 has neither aggregation nor
vesicle leakage activity with pure neutral (DOPC) vesicles, as
previously reported for RNase 3 [13]. Confocal microscopy results
also revealed the lack of activity of both RNases on neutral liposomes
(Fig. 4B). These results indicate that both, RNase 3 and RNase 7
mechanisms are electrostatically driven, as depletion of liposome
charge practically abolishes protein–membrane interactions. As a
result of the protein interaction with the phospholipid heads, the net
charge of the environment would be reduced, and hydrophobic
interactions would be promoted, and could perturb the phospholipid
acyl chain core. These events would lead to the membrane
destabilization and can explain the observed leakage of the entrapped
low molecular weight markers and the micellation process visualized
by confocal microscopy.
Although a ﬁrst protein–lipid association step would be driven by
electrostatic forces, leading to a ﬁnal membrane disruption event for
both RNases, further analysis of the interaction process reveals distinct
mechanisms of action. We observe a differentiated timing and
protein/lipid molar ratio required for the each of the membrane
destabilization steps: vesicles content leakage, aggregation and
sample precipitation (Figs. 2, 3, 4 and 6). RNase 3 triggers ﬁrst the
liposome aggregation while RNase 7 induces the liposomes content
release before their aggregation (Fig. 3). In terms of protein/lipid
molar ratio, whereas RNase 7 can induce leakage at a ratio of 1/900,
RNase 3 requires a higher ratio (around 1/300) for a signiﬁcant
release of the liposome entrapped content (Fig. 2). On the other hand,
whereas RNase 3 can trigger liposome aggregation at a very low
protein/lipid ratio (b1/1000), RNase 7 needs a much higher ratio (1/
400). These results indicate that vesicle aggregation is a key event for
RNase 3 mechanism, whereas for RNase 7 the leakage event, rather
than the vesicle aggregation ability, may represent the key triggering
membrane destabilization step. Therefore, the comparative results
indicate that for RNase 7, the ﬁrst membrane destabilization step
would represent only a local event, as the liposome content release is
exclusive for the ANTS low molecular weight compound, whereas the
high molecular weight tested compound concanavalin remains inside,
even at much higher protein concentration (Fig. 7). Direct comparison
of both leakage and liposome aggregation also conﬁrms for RNase 7
that when a signiﬁcant percentage of the leakage is already registered,
the original vesicle population remains unaltered (Fig. 3). Besides, the
lack of signiﬁcant conformational change uponmembrane interaction,
as assessed by FTIR, also discards the formation of structured porus.
We can propose that for both proteins, the membrane lysis would
depend on the protein association to the lipid bilayer. The lack of
activity for neutral vesicles indicates that association is driven by
electrostatic interactions. Hydrophobic interactions might be involved
then in the protein partial insertion and/or protein–protein binding.
The accumulation of protein units at the membrane would ﬁnally
induce its local destabilization.
Neither leakage nor aggregation ability was found for pancreatic
ribonuclease A [12,13]. No membrane destabilization activity was
either reported for the other eosinophil RNase, the eosinophil derived
neurotoxin, EDN [15]. Protein aggregation prediction proﬁle for the
RNase A family members can support a differential sequence
determinant for RNase 3 lipid vesicle aggregation ability [35]. A
conserved pattern corresponding to the beta core of the protein,
common to all ribonucleases is observed in all cases. On the contrary,more differences are observed at the N-terminus part. Whereas RNase
1, the human RNase A homolog, has a very low aggregation tendency
in the N-terminus region, RNase 3 and RNase 7 present a higher
aggregation propensity value. RNase 3 has indeed a hydrophobic
patch at the N-terminus, with a higher propensity value spanning a
more extensive region (from residues 8 to 18 and from 23 to 30).
Scanning of RNase 7 shows only a narrower sequence corresponding
to the ﬁrst of the two N-terminus regions for RNase 3. These results
may explain the higher capacity of RNase 3 to aggregate liposomes in
comparison with RNase 7. We can propose that protein–protein
interactions, favoured by association between hydrophobic patches,
would mostly favour in RNase 3 the creation of an aggregation
nucleus, which would trigger the liposomes precipitation process. The
sigmoidal proﬁle for the aggregation and leakage activities, as a
function of the protein concentration (Fig. 2), suggests a dependence
of the mechanism of action on the protein self aggregation from a
threshold concentration value. In fact, we did visualize the presence of
RNase 3 aggregated patches at the cell surface in the characterization
of the cytotoxic process in eukaryote cell cultures [36].
We have also analysed the protein primary sequences to screen
for potential signiﬁcant differences for antimicrobial RNases (Fig. 1).
Although, binding of cationic antimicrobial peptides to the cyto-
plasmic membrane does not appear to involve speciﬁc binding sites
[37,38], some sequence determinants are reported for antimicrobial
peptides. It is generally accepted that antimicrobial proteins and
peptides need a combination of charged and hydrophobic amino acid
residues [39–43]. Although ECP/RNase 3 and RNase 7 show only a
38% of sequence identity (Fig. 1), both share a high cationicity (with
corresponding pI values of about 11 and 10 respectively), which
should be critical for their antibacterial activity. However, careful
inspection of their residue speciﬁcity indicates that their cationic
character was acquired independently during the RNase A family
evolution. While RNase 3 has incorpored a high number of arginine
residues (18 Arg/1 Lys), during its divergence from the eosinophil
RNases common precursor[44], RNase 7 presents an unusual high
content of lysines (18 Lys/4 Arg), The positively charged/hydro-
phobic ratio has also been considered for comparison. RNase 3
presents a ratio of 19/42, while RNase 7 presents a lower ratio (22/
51) (Fig. 1). These differences may also contribute to the observed
distinct mechanisms for both ribonucleases. However, position and
properties of hydrophobic residues should also be taken into
consideration. The design of peptides with improved activity by
high-throughput screening [45] indicates that some amino acid
positions did not easily accept substitutions. A predictive methodol-
ogy approach for the identiﬁcation of active domains in antimicro-
bial proteins based on previous high-throughput screening results
(Torrent et al., submitted) suggests a distinct pattern for RNase 3 and
7 potential active domains.
Fig. 9 tries to illustrate the proposed sequence of events involved in
the protein–membrane association process, in an effort to interpret
our experimental data accordingly to the described theoretical models
from the literature [39,46,47]. Main steps of the proposed mechanism
for each RNase could be summarized as follows. For RNase 3: 1)
binding of the protein to the membrane phospholipid polar heads by
electrostatic interactions; 2) clustering of the liposome–protein
complexes; 3) liposome aggregation and destabilization of the lipid
bilayer and 4) precipitate formation with the consequent membrane
disruption and release of the liposome content. As for RNase 7, some of
the events would occur in a distinct chronology: 1) binding of the
protein to the membrane by electrostatic interactions; 2) local
membrane destabilization allowing the formation of transient
“holes”; 3) clustering of liposomes and 4) aggregation and ﬁnal
precipitate formation.
Interestingly, the expression pattern of these two RNases differs
substantially. Whereas RNase 3 is mainly found in eosinophils, RNase
7 is expressed in multiple somatic tissues and predominantly in the
1125M. Torrent et al. / Biochimica et Biophysica Acta 1788 (2009) 1116–1125skin epithelial tissue. Their differential expression pattern and the
current reported results on their action at the membrane level,
suggest that these two RNases may be recruited for targeting different
pathogens in vivo.
The pathogen selection may be reﬂected by a distinct cytotoxic
mechanism, which is probably partly dependent on its membrane
interaction mechanism, although other events that could take place at
the bacterial wall level should also be considered. In fact, action at
both the bacteria surface and cytoplasmic membrane do reveal a
combined contribution ([14]; Torrent et al., unpublished results).
Further characterization of RNases 3 and 7 properties will have to be
carried to determine their pathogen target speciﬁcity and their
biological functions.
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